-
Regen BioPharma Files Immuno-Oncology Patent Application
americanpharmaceuticalreview
August 09, 2019
Regen BioPharma has announced the filing of a US patent application covering a newly discovered synergy between inhibition of NR2F6 and cannabidiol (CBD). The new data demonstrates enhanced ability to reduce cancer growth in ...
-
Enbrel and Its Patent Layout: The Period of Market Exclusivity until 2029!
PharmaSources/zhixing
July 30, 2019
Patents are fortresses of new drugs. The patent layout of Enbrel is quite impressive: the span from the first application in 1995 to the patent expiration in 2029 reaches 34 years.
-
USPTO Issues Patent for COM701, Anti-PD-1 Antibody Use
americanpharmaceuticalreview
July 17, 2019
Compugen announced the United States Patent and Trademark Office (USPTO) has granted a new patent covering method of use of COM701, a first-in-class therapeutic antibody targeting PVRIG, in combination with anti-PD-1 antibodies.
-
Amgen wins patent block on Sanofi drug rival
drugs
July 16, 2019
Amgen has successfully blocked the manufacture, sales and marketing of its Sanofi drug rival in Germany.
-
Patent Covering Manufacturing Process of M-001 Universal Flu Vaccine Allowed in USA, Japan
americanpharmaceuticalreview
June 20, 2019
BiondVax Pharmaceuticals announced a patent covering production processes of the Company's M-001 universal influenza vaccine candidate was allowed in the USA and Japan.
-
Intec Pharma Granted European Patent
americanpharmaceuticalreview
May 22, 2019
Intec Pharma has announced the European Patent Office has granted the Company European Patent No. 2997953 titled, "DELIVERY DEVICE FOR ORAL INTAKE OF AN AGENT," and ...
-
The discoveries made through ‘routine’ research can now be patentable
europeanpharmaceuticalreview
April 02, 2019
In a ruling handed down on 27 March 2019 by the UK Supreme Court, Lord Hodge has confirmed that discoveries made through well-established or routine research protocols can be rewarded with a patent…
-
European firms fuel growth in patent applications
europeanpharmaceuticalreview
March 14, 2019
Pharmaceutical and biotechnology patent applications increased by 13 percent last year, with over 6,000 applications coming from European companies…
-
P&P biotech obtains US patent for its platform technology
biospectrumasia
March 11, 2019
The patented platform technology developed by a Chinese firm is the first of its kind worldwide as well as the first to have been approved by the U.S. Patent Office.
-
Merck Granted U.S. Patent for novel combination of Artificial Intelligence and Blockchain Technology
worldpharmanews
January 31, 2019
Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO).